UK pharmaceutical group increases its offer to about $14 a share, possibly brining to an end its three -month hostile courtship of the biotech company
Financial Times - US homepage, Financial Times
Mon, 07/16/2012 - 4:46am
UK pharmaceutical group increases its offer to about $14 a share, possibly brining to an end its three -month hostile courtship of the biotech company